Cite Filings / CLDX / 0000902219-25-000286

Feed Companies Filings Check

Sign in

SCHEDULE 13G/A

Statement of Beneficial Ownership

Celldex Therapeutics, Inc. Filed 2025-08-12 Acc 0000902219-25-000286

Documents 1

SCHEDULE 13G/A Statement of Beneficial Ownership , xslSCHEDULE_13G_X01/primary_doc.xml

Around this filing

2025-08-19 8-K Other events
2025-08-15 4 SVP & GENERAL COUNSEL sold 771 shares at an average $24.77 ($19,096)
2025-08-14 SCHEDULE 13G/A Statement of Beneficial Ownership
2025-08-12 SCHEDULE 13G/A Statement of Beneficial Ownership
2025-08-07 10-Q Quarterly Report
2025-08-07 8-K Results of operations
2025-05-15 SCHEDULE 13G/A Statement of Beneficial Ownership

Link to a passage

Paste a passage to link it

At least 12 characters, not counting spaces, so the link points to one passage.

External

SEC EDGAR (opens in new tab)

Loading xslSCHEDULE_13G_X01/primary_doc.xml…

Connection lost

Reconnecting…

Cite Filings isn't responding

Reconnecting…